Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Understanding Lipoproteins: Key Players in Cardiovascular Health

Laurence Shen

Lipoproteins, complex molecular assemblies of lipids and proteins, are essential components of the circulatory
system, serving as vehicles for the transport of lipids, including cholesterol and triglycerides, throughout the body.
This article provides an overview of lipoproteins, their various types, functions, and their critical role in cardiovascular
health. Understanding the significance of lipoproteins is crucial as imbalances in their levels are intimately linked to the
development of atherosclerosis and coronary heart disease. We explore the roles of chylomicrons, very-low-density
lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL) in lipid transport and their
impact on cardiovascular health. Dyslipidemia, characterized by abnormal lipoprotein levels, is a common risk factor
for cardiovascular disease, and lifestyle modifications, as well as medication, are essential tools for managing these
levels. We also discuss the latest research in the field and the potential future directions in lipoprotein-related therapies.
By comprehending the roles and regulation of lipoproteins, individuals can take proactive steps to safeguard their
cardiovascular health and reduce the risk of heart disease.